Supriya Lifescience Ltd

NSE: SUPRIYA · BSE: 543434 · Pharmaceuticals & Biotechnology · 36 announcements

Share price: ₹632.10
Market cap: ₹5,087 Cr
Revenue (annual): ₹827.9 Cr
Net profit (annual): ₹209.1 Cr
P/E (TTM): 28.7×Sector 43.7×
Promoter holding: 68.30%+0.00% QoQ
FII holding: 6.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Nov 2026 15:38 IST BSE

Earnings Call

Supriya Lifescience Earnings Call Transcript: Key Takeaways

Q2 FY27 revenue ₹206 Cr (+3.2% YoY), EBITDA ₹45 Cr (-37.5%), margin 22%. LATAM regulatory shock, Ambernath ramp-up costs and raw material inflation hit margins; FY27 margin guidance cut to 23–25%.

Call: Guides 20% growth

Open call summary → Read the filing ↗